Status:
COMPLETED
Prematurity-Related Ventilatory Control
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Respiratory Control in Premature Infants
Eligibility:
All Genders
1-28 years
Brief Summary
The purpose of this research study is to improve our understanding of unstable breathing and heart blood flow patterns seen in premature infants. The investigator will use novel non-invasive measures ...
Detailed Description
The investigator will look at results of breathing tests, non-invasive sound wave (ultrasound) test of the heart and blood vessel (Echocardiography), and a sample of blood to see if it is possible for...
Eligibility Criteria
Inclusion
- All infants born between 24 0/7 and 28 6/7 weeks GA admitted to the Neonatal Intensive Care Unit at St. Louis Children's Hospital will be considered for enrollment.
Exclusion
- Infants not likely to survive
- Infant with significant heart disease
- Infant with a significant congenital abnormalities of the central nervous system, nose, mouth lungs or ribs, or congenital diseases that affect lung growth
- Physician refusal
- Unlikely that the infant will be available for 52-week follow-up visit.
Key Trial Info
Start Date :
May 14 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 9 2022
Estimated Enrollment :
177 Patients enrolled
Trial Details
Trial ID
NCT03464396
Start Date
May 14 2018
End Date
March 9 2022
Last Update
January 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University
St Louis, Missouri, United States, 63110